TET2

GPTKB entity

Statements (68)
Predicate Object
gptkbp:instance_of gptkb:DNA
gptkbp:associated_with gptkb:myelodysplastic_syndromes
gptkb:Oncology
gptkbp:code gptkb:ten-eleven_translocation_methylcytosine_dioxygenase_2
gptkbp:discovered_by gptkb:2010
gptkbp:function DNA demethylation
gptkbp:genetic_studies somatic mutation
gptkbp:has_role cell differentiation
gptkbp:has_variants gptkb:TET2_D140_Y
gptkb:TET2_G127_D
gptkb:TET2_K111_N
gptkb:TET2_Q261_R
gptkb:TET2_R140_Q
https://www.w3.org/2000/01/rdf-schema#label TET2
gptkbp:initiated_by tumorigenesis
gptkbp:interacts_with gptkb:IDH1
gptkb:IDH2
gptkbp:involved_in cancer progression
epigenetic regulation
gptkbp:is_associated_with gptkb:chronic_myelomonocytic_leukemia
disease progression
genomic instability
tumor heterogeneity
therapeutic efficacy
solid tumors
therapeutic resistance
hypermutation
hypomethylation
gptkbp:is_expressed_in various tissues
cancer stem cells
hematopoietic cells
normal tissues
gptkbp:is_involved_in cell cycle regulation
cellular homeostasis
cellular metabolism
developmental processes
metabolic processes
DNA repair mechanisms
cell signaling pathways
cellular aging
stem cell maintenance
cellular signaling
transcriptional regulation
cellular repair mechanisms
cellular differentiation pathways
cellular responses to stress
gptkbp:is_linked_to immune response
cancer evolution
tumor microenvironment
treatment resistance
epigenetic alterations
poor prognosis in AML
gptkbp:is_part_of epigenetic landscape
cancer genomics
gene regulatory networks
cancer biology research
cancer pathways
epigenetic modification pathways
gptkbp:is_regulated_by transcription factors
gptkbp:is_studied_for biomarker potential
therapeutic targeting
gptkbp:is_studied_in clinical trials
cancer research
gptkbp:located_in gptkb:human_chromosome_4q24
gptkbp:related_to gptkb:TET_family_of_proteins
gptkbp:targets therapeutic agents
gptkbp:bfsParent gptkb:myelodysplastic_syndromes
gptkbp:bfsLayer 5